SCHEMBL20845334

SCHEMBL20845334

C1=C\c2ccc(-c3nc(-c4cccc(-c5cccnc5)c4)nc(-c4cccc(-c5cccnc5)c4)n3)cc2-c2ccc3ccccc3c2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ CYP11B1 P15538 8/20 0.39
▸ CYP11B2 P19099 7/20 0.39
▸ CYP19A1 P11511 4/20 0.39
▸ CYP17A1 P05093 3/20 0.39
▸ NPC1 O15118 4/20 0.35
▸ PGR P06401 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ BCHE P06276 1/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845249 0.94 RAB9A (0.37) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845093 0.91 DHODH (0.38) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845333 0.90 KDM4E (0.33) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL20222629 0.90 CYP11B1 (0.43) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845087 0.90 DHODH (0.37) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845240 0.89 KDM4E (0.34) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL20845247 0.88 DHODH (0.38) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845314 0.88 CYP11B1 (0.41) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845018 0.88 ALDH1A1 (0.39) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL20845251 0.88 KDM4E (0.36) RAB9AKDM4EMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 RAB9A 635/4885KDM4E 631/4885MAPT 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback